These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28488314)

  • 1. Pharmacist intervention to detect drug adverse events on admission to the emergency department: Two case reports of neuroleptic malignant syndrome.
    Leenhardt F; Perier D; Pinzani V; Giraud I; Villiet M; Castet-Nicolas A; Gourhant V; Breuker C
    J Clin Pharm Ther; 2017 Aug; 42(4):502-505. PubMed ID: 28488314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical neuroleptic malignant syndrome with long-term clozapine.
    Corallo CE; Ernest D
    Crit Care Resusc; 2007 Dec; 9(4):338-40. PubMed ID: 18052897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome: case report and discussion.
    Chandran GJ; Mikler JR; Keegan DL
    CMAJ; 2003 Sep; 169(5):439-42. PubMed ID: 12952806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partnered pharmacist charting on admission in the General Medical and Emergency Short-stay Unit - a cluster-randomised controlled trial in patients with complex medication regimens.
    Tong EY; Roman C; Mitra B; Yip G; Gibbs H; Newnham H; Smit DP; Galbraith K; Dooley MJ
    J Clin Pharm Ther; 2016 Aug; 41(4):414-8. PubMed ID: 27255463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.
    Karagianis JL; Phillips LC; Hogan KP; LeDrew KK
    Ann Pharmacother; 1999 May; 33(5):623-30. PubMed ID: 10369628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant neuroleptic syndrome in patients with dementia].
    Malling BJ
    Ugeskr Laeger; 1999 Apr; 161(17):2541-2. PubMed ID: 10327877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of clozapine-induced neuroleptic malignant syndrome.
    Miller DD; Sharafuddin MJ; Kathol RG
    J Clin Psychiatry; 1991 Mar; 52(3):99-101. PubMed ID: 1672311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome associated with clozapine use.
    Anderson ES; Powers PS
    J Clin Psychiatry; 1991 Mar; 52(3):102-4. PubMed ID: 2005071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication.
    Blum MW; Siegel AM; Meier R; Hess K
    Eur Neurol; 2001; 46(3):158-60. PubMed ID: 11598337
    [No Abstract]   [Full Text] [Related]  

  • 16. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS.
    Illing M; Ancill R
    Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
    Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ
    Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.